Drug Profile
Metoclopramide rapidly disintegrating tablet - Salix Pharmaceuticals/Wilmington Pharmaceuticals
Alternative Names: Metoclopramide-Zydis; METOZOLV ODTLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Wilmington Pharmaceuticals LLC
- Developer Salix Pharmaceuticals
- Class Aminobenzoic acids; Antiemetics; Antineoplastics; Benzamides; Chlorobenzenes; Diethylamines; Gastrokinetics; Phenyl ethers; Radiation-sensitising agents; Radiosensitisers; Small molecules
- Mechanism of Action Dopamine receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Diabetic gastroparesis; Gastro-oesophageal reflux
Most Recent Events
- 01 Apr 2015 Salix Pharmaceuticals has been acquired by Valeant Pharmaceuticals International
- 09 Sep 2009 Registered for Diabetic gastroparesis in USA (PO)
- 09 Sep 2009 Registered for Gastro-oesophageal reflux in USA (PO)